2021 Mar. 23 11:30 AM
2021 Mar. 23 13:00 PM
Permanent Mission of Zambia to the WTO and UNIDO
Mobilizing Resources to Build Resilient Local Pharmaceutical Manufacturing Industries in Developing Countries - Challenges and Opportunities
The COVID-19 pandemic has highlighted the strategic imperative of building resilient manufacturing capacity for essential medicines and vaccines in developing countries and regions. There is the potential to improve availability of essential medicines and accelerate access to novel products whilst protecting the innovation ecosystems that have so rapidly developed COVID19 vaccines. Developing the assets that can achieve these ends requires an ecosystem that ensures sustainable high-quality production. Requisite components of such systems include a conducive environment that supports investment, access to markets, robust regulatory oversight, and access to technology. Africa bears a disproportionate burden of disease and is dependent on imports for many essential medicines and most vaccines. The disruption to global supply chains caused by the COVID 19 pandemic has highlighted the vulnerability of the continent and underlines the need to strengthen local production of these products. There are ongoing initiatives in this field, but accelerated progress requires a redoubling of efforts. Coordinated application of ´push´ and ´pull´ interventions could help build conducive environments and establish the market returns that will stimulate investment. The international community can play a catalytic role by targeting Official Development Assistance and Other Official Flows through a combination of capacity building, budget support, and market commitments/signalling. This adjustment will accelerate progress towards sustainable industry sectors in medicines and vaccines and lead to improved and more resilient access in Africa and other developing regions of the world.
The session considered issues, including:
- • Challenges hampering progression of the pharmaceutical industry in Africa;
- • Opportunities for accelerated industrial development of the pharmaceutical sector to i.a. better prepare the continent for future pandemics and crises;
- • Voluntary licensing and technology transfer as a means to increase access to innovative medicines and vaccines;
- • Targeted official development assistance and other official flows to accelerate transformational change of the pharmaceutical sector;
- • The role that the international pharmaceutical industry could play in supporting the development of the sector in Africa.
Finally, the panel considered how international interest in pharmaceutical industry development in Africa can be harnessed to build and sustain momentum for the long-term benefit of all.
- H.E. Mrs. Martha Lungu MWITUMWA, Ambassador, Permanent Representative of Zambia to UNIDO and to the UN and other International Organizations in Geneva, and Chair of the Friends of Industry and Innovation
- Mr. Günter Nooke – Personal Representative of the German Chancellor for Africa (TBC)
- Mr. Stanley Okolo – Director General, West African Health Organisation (WAHO)
- Ms. Christianah Mojisola Adeyeye – Director General, National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria
- Mr. Adbu Mukhtar – Director, Industrial and Trade Development, African Development Bank (AfDB)
- Mr. Bernardo Calzadilla-Sarmiento – Managing Director, Directorate of Digitalization, Technology and Agri-Business, United Nations Industrial Development Organization (UNIDO)
Interpretation services will be available in English and French.
Find out more about the Aid-for-Trade event here.
Related articles and publications
- COVID-19: Long-term support for biotech yields vaccine promise in Cuba
- Roadmaps for developing the pharmaceutical industry in West Africa
- Project Publications Pharmaceutical Sector
Other sessions at the WTO Aid for Trade Stocktaking event
- AfDB-UNIDO-ITC session: "Implementing the AfCFTA: the Need for Deepening Private Sector Engagement and Commitment", 24 March, 11.00-12.30 am CET
- LDC Group session: "Developing Production and Supply Capacities of Medical Equipment and Pharmaceutical Products in LDCs: the Role of Aid for Trade" 23 March, 11.00-12.30 am CET